What is the ticker symbol for Ligand Pharmaceuticals Incorporated?

The ticker symbol for Ligand Pharmaceuticals Incorporated is NASDAQ:LGND

Does Ligand Pharmaceuticals Incorporated pay dividends?

No, Ligand Pharmaceuticals Incorporated does not pay dividends

What sector is Ligand Pharmaceuticals Incorporated in?

Ligand Pharmaceuticals Incorporated is in the Healthcare sector

What industry is Ligand Pharmaceuticals Incorporated in?

Ligand Pharmaceuticals Incorporated is in the Biotechnology industry

What country is Ligand Pharmaceuticals Incorporated based in?

Ligand Pharmaceuticals Incorporated is headquartered in United States

When did Ligand Pharmaceuticals Incorporated go public?

Ligand Pharmaceuticals Incorporated initial public offering (IPO) was on November 18, 1992

Is Ligand Pharmaceuticals Incorporated in the S&P 500?

No, Ligand Pharmaceuticals Incorporated is not included in the S&P 500 index

Is Ligand Pharmaceuticals Incorporated in the NASDAQ 100?

No, Ligand Pharmaceuticals Incorporated is not included in the NASDAQ 100 index

Is Ligand Pharmaceuticals Incorporated in the Dow Jones?

No, Ligand Pharmaceuticals Incorporated is not included in the Dow Jones index

When was Ligand Pharmaceuticals Incorporated last earnings report?

Ligand Pharmaceuticals Incorporated's most recent earnings report was on August 6, 2026

When does Ligand Pharmaceuticals Incorporated report earnings?

The next expected earnings date for Ligand Pharmaceuticals Incorporated is November 5, 2026

LGND Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, LGND price is $288.83, up +1.13% on September 8, 2026
Current Price All-Time High: LGND price is currently -11.57% below its historical high of $326.63 set on July 8, 2026
Market Cap: LGND current market cap is $6B, up +78.85% over the past 365 days
PE Ratio: LGND current PE ratio is 30.88
Revenue: LGND current annual revenue is $268.09M, up +60.40% year-over-year
Next Earnings: The next earnings release for LGND is on November 5, 2026

Profile

Company profile for Ligand Pharmaceuticals Incorporated (LGND)
Metric	Value
Full Name	Ligand Pharmaceuticals Incorporated
Ticker	NASDAQ: LGND
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Nov 18, 1992
Indexes	Not included
Website	ligand.com
Employees	68

Key Metrics

Ligand Pharmaceuticals Incorporated Key Details
Metric	Value	Date
Price	$288.83	Sep 8, 26
Price, 1D Change	+1.13%	Sep 8, 26
	$6B	Sep 8, 26
	-	Sep 8, 26
	30.88	Sep 8, 26
	0.81	Sep 8, 26
	$268.09M	Dec 31, 25
Revenue, 1Y Change	+60.40%	Dec 31, 25
	$6.13	Dec 31, 25
EPS, 1Y Change	+2,882.44%	Dec 31, 25

Events

Ligand Pharmaceuticals Incorporated Events
Metric	Value	Date
Next Earnings		Nov 5, 26
Last Qtr. Earnings		Aug 6, 26
Last Ann. Earnings		Feb 26, 26
Last Ex-Dividend	$9.15	Apr 3, 07
Next Ex-Dividend	N/A	N/A
Last Split	1603:1000	Nov 2, 22
Next Split	N/A	N/A
Last Ticker Change	LGNDD	Dec 21, 10
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

LGND Estimates
Metric	Value	Date
	$6.13	Dec 31, 25
EPS Estimate	$9.32	N/A
EPS Est. Change	+51.90%	N/A
	$268.09M	Dec 31, 25
Revenue Estimate	$289.83M	N/A
Revenue Est. Change	+8.11%	N/A
Current Price	$288.83	Sep 8, 26
Price Target	$345.00	-
Price Tgt. Change	+19.45%	-

🔒 Log In To Unlock Full Data

EPS

LGND EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$5.66	-$0.22	-103.90%
2025	$7.58	$6.13	-19.10%
2026	$9.32	N/A	+51.90%
2027	$11.93	N/A	+94.62%

Revenue

LGND revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$163.37M	$167.13M	+2.30%
2025	$264.01M	$268.09M	+1.54%
2026	$289.83M	N/A	+8.11%
2027	$380.50M	N/A	+41.93%

🔒 Log In To Unlock Full Data

Performance

LGND Performance
Metric	Value	Date
Price, 1Y	+74.14%	Sep 8, 26
Price, 3Y	+358.10%	Sep 8, 26
	+78.85%	Sep 8, 26
	+426.30%	Sep 8, 26
	+60.40%	Dec 31, 25
	+36.61%	Dec 31, 25
	+2,882.44%	Dec 31, 25
	+410.07%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

LGND Technical Indicators
Metric	Value	Date
Current Price	$288.83	Sep 8, 26
	$232.80	Sep 8, 26
	$297.23	Sep 8, 26
	$239.84	Sep 8, 26
	$285.27	Sep 8, 26
	-$1.64	Sep 8, 26
	0.81	Sep 8, 26
	$9.30	Sep 8, 26
	50.36	Sep 8, 26
	19.99%	Sep 8, 26

Dividends

LGND Dividends
Metric	Value	Date
Last Paid	$9.15	Apr 3, 07
Upcoming	N/A	N/A
	-	Sep 8, 26
Total Dividend	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

LGND Income & Profitability
Metric	Value	Date
	$268.09M	Dec 31, 25
	$6.13	Dec 31, 25
	$261.50M	Dec 31, 25
	97.54%	Dec 31, 25
	$47.20M	Dec 31, 25
	17.61%	Dec 31, 25
	$124.45M	Dec 31, 25
	46.42%	Dec 31, 25
	$82.92M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

LGND Financial Health
Metric	Value	Date
	0.44	Dec 31, 25
	22.23	Dec 31, 25
	21.98	Dec 31, 25
	-	Dec 31, 25
	5	Jun 30, 26
	7.79	Sep 8, 26

Valuations

LGND Valuations
Metric	Value	Date
	30.88	Sep 8, 26
	19.82	Sep 8, 26
	5.95	Sep 8, 26
	41.17	Sep 8, 26
	-	N/A

Balance Sheet

LGND Balance Sheet
Metric	Value	Date
	$1.02B	Dec 31, 25
	$733.52M	Dec 31, 25
	$1.56B	Dec 31, 25
	$832.27M	Dec 31, 25
	$543.43M	Dec 31, 25
	$37.45M	Dec 31, 25
	$451.49M	Dec 31, 25
	$1.10M	Dec 31, 25
	$34.69M	Dec 31, 25

Expenses

LGND Expenses
Metric	Value	Date
	$143.63M	Dec 31, 25
	$214.30M	Dec 31, 25
	$47.26M	Dec 31, 25
	$92.45M	Dec 31, 25
	$35.72M	Dec 31, 25
	$0.00	Dec 31, 25
	$34.51M	Dec 31, 25

Cash Flow

LGND Cash Flow
Metric	Value	Date
	$49.36M	Dec 31, 25
	-$377.32M	Dec 31, 25
	$428.22M	Dec 31, 25
	$11.31M	Dec 31, 25
	$38.05M	Dec 31, 25

Recent analyst updates

LGND Recent analyst updates
Metric	Value	Date
Leerink Partners		Aug 14, 26
RBC Capital	→	Aug 7, 26
HC Wainwright & Co.	→	Aug 6, 26
Oppenheimer	→	Aug 3, 26
RBC Capital	→	Jul 15, 26
B of A Securities	→	Jul 9, 26
Stifel	→	Jul 8, 26
RBC Capital	→	May 8, 26
HC Wainwright & Co.	→	Apr 30, 26
RBC Capital	→	Apr 28, 26

Analyst sentiment

Institutional ownership

No data

Screeners with LGND

FAQ

What is the ticker symbol for Ligand Pharmaceuticals Incorporated?: The ticker symbol for Ligand Pharmaceuticals Incorporated is NASDAQ:LGND
Does Ligand Pharmaceuticals Incorporated pay dividends?: No, Ligand Pharmaceuticals Incorporated does not pay dividends
What sector is Ligand Pharmaceuticals Incorporated in?: Ligand Pharmaceuticals Incorporated is in the Healthcare sector
What industry is Ligand Pharmaceuticals Incorporated in?: Ligand Pharmaceuticals Incorporated is in the Biotechnology industry
What country is Ligand Pharmaceuticals Incorporated based in?: Ligand Pharmaceuticals Incorporated is headquartered in United States
When did Ligand Pharmaceuticals Incorporated go public?: Ligand Pharmaceuticals Incorporated initial public offering (IPO) was on November 18, 1992
Is Ligand Pharmaceuticals Incorporated in the S&P 500?: No, Ligand Pharmaceuticals Incorporated is not included in the S&P 500 index
Is Ligand Pharmaceuticals Incorporated in the NASDAQ 100?: No, Ligand Pharmaceuticals Incorporated is not included in the NASDAQ 100 index
Is Ligand Pharmaceuticals Incorporated in the Dow Jones?: No, Ligand Pharmaceuticals Incorporated is not included in the Dow Jones index
When was Ligand Pharmaceuticals Incorporated last earnings report?: Ligand Pharmaceuticals Incorporated's most recent earnings report was on August 6, 2026
When does Ligand Pharmaceuticals Incorporated report earnings?: The next expected earnings date for Ligand Pharmaceuticals Incorporated is November 5, 2026

Data Sources & References

LGND Official Website www.ligand.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/886163/000088616326000006/0000886163-26-000006-index.htm
LGND Profile on Yahoo Finance finance.yahoo.com/quote/LGND
LGND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lgnd